Advanced search

You are here: Home / Our work / ABPI library / Guidelines / Best practice model for the disclosure of results and transparent information on clinical trials

Best practice model for the disclosure of results and transparent information on clinical trials

Publication date: 25/06/2008

Publication ref:

Open access to clinical trial information is becoming increasingly important to policymakers, healthcare professionals, patients and the general public. This document sets out guidance for the pharmaceutical industry to encourage greater transparency about the information gained from clinical trials. It is a working document that will be will be subject to regular review.

Document size: 79KB

Download this document

Print this page

Get in touch

Please choose the subject of your enquiry from the list below:

Enter the above code here:

Can't read? Try different words.

Submit

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.

The Association of the British Pharmaceutical Industry

7th floor, Southside, 105 Victoria Street,
London, SW1E 6QT
Telephone +44 (0) 870 890 4333
ABPI Cymru Wales
ABPI Northern Ireland
ABPI Scotland

The Prescription Medicines Code of Practice Authority (PMCPA) is responsible for administering the ABPI Code of Practice for the Pharmaceutical Industry at arm's length of the ABPI itself.

The Office of Health Economics (OHE) provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.